AUG 24, 2020 9:32 AM PDT

New Drug Reduces Swelling in Asthma and COPD

WRITTEN BY: Annie Lennon

Researchers from the University of Glasgow, Scotland, and the University of Technology Sydney in Australia have identified a protein in the lungs that, once activated, could allow patients with asthma and chronic obstructive pulmonary disease (COPD) to breathe more easily. 

Previous research has found that a protein present in the gut and pancreas known as 'free fatty acid receptor 4' (FFA4) can be activated by dietary fats to regulate glucose levels in the blood. In the most recent study, however, the researchers found that the protein also lives in the human lungs. 

Studying it more closely, they then found that targeting the FFA4 receptor in the lungs was able to reduce swelling and difficulty breathing among those with asthma and COPD. To do so, they developed a new class of drugs that activate FFA4 in the lungs of mice. Relaxing the muscles around their airways, the drug not only enabled more air to enter their lungs but also reduce inflammation caused by pollution, cigarette smoke, and allergens, including dust mites. 

"It was indeed a surprise to find that by targeting a protein that up to now has been thought of as being activated by fish oils in our diet we were able to relax airway muscle and prevent inflammation," says Andrew Tobin, one of the study's authors. "We are optimistic that we can extend our findings and develop a new drug treatment of asthma and COPD."

Although promising, the research is still in very early stages, and thus it will take some time for the drugs to be tested out in human trials and eventually make it to clinical use. Ultimately, however, the researchers hope that their discovery will go on to develop into new medicines for patients that don't respond to existing treatments for both asthma and COPD. 

 

Sources: New AtlasAAAS

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUL 12, 2021
Cannabis Sciences
How does CBD Affect Heart Arrhythmia?
JUL 12, 2021
How does CBD Affect Heart Arrhythmia?
Heart arrhythmias happen when the heart beats too fast, too slow, or irregularly. According to the Centers for Dise ...
AUG 03, 2021
Drug Discovery & Development
A pediatric-friendly drug to combat snail fever
AUG 03, 2021
A pediatric-friendly drug to combat snail fever
           Schistosomiasis, also known as Bilharzia or snail fever, is a disease  ...
AUG 08, 2021
Microbiology
Manganese Could be an Achilles' Heel for Some Pneumonia Germs
AUG 08, 2021
Manganese Could be an Achilles' Heel for Some Pneumonia Germs
Researchers recently discovered bacteria that fed on the element manganese. Scientists also know that some bacterial pat ...
AUG 10, 2021
Microbiology
Herbal Medicine May Help Restore the Microbiome, Treat Gulf War Illnesses
AUG 10, 2021
Herbal Medicine May Help Restore the Microbiome, Treat Gulf War Illnesses
About one-third of Gulf war veterans have chronic and unexplained medical issues that include gastrointestinal disorders ...
AUG 13, 2021
Cell & Molecular Biology
Taking Aim at the Sugar Coat of the SARS-CoV-2 Spike Protein
AUG 13, 2021
Taking Aim at the Sugar Coat of the SARS-CoV-2 Spike Protein
We've learned a lot about the virus that causes COVID-19, SARS-CoV-2, in the past year and a half. Researchers know the ...
AUG 24, 2021
Drug Discovery & Development
A comparison of drugs for relapsing-remitting multiple sclerosis.
AUG 24, 2021
A comparison of drugs for relapsing-remitting multiple sclerosis.
     Multiple sclerosis (MS) is a rare and unpredictable autoimmune disease in which the body’s inn ...
Loading Comments...